Iovance Biotherapeutics, Inc.
IOVA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$372,177 | -$444,037 | -$395,893 | -$342,252 |
| Dep. & Amort. | $43,606 | $33,127 | $21,135 | $13,980 |
| Deferred Tax | -$2,828 | -$3,479 | $0 | $0 |
| Stock-Based Comp. | $109,627 | $62,625 | $84,022 | $69,765 |
| Change in WC | -$122,556 | -$6,521 | -$2,892 | $24,553 |
| Other Non-Cash | -$8,649 | -$3,535 | $871 | $6,013 |
| Operating Cash Flow | -$352,977 | -$361,820 | -$292,757 | -$227,941 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,069 | -$22,290 | -$20,425 | -$37,574 |
| Net Acquisitions | -$52,573 | -$212,633 | -$276,880 | -$37,706 |
| Inv. Purchases | -$460,769 | -$205,902 | -$245,816 | -$725,208 |
| Inv. Sales/Matur. | $428,000 | $285,583 | $522,696 | $762,914 |
| Other Inv. Act. | $0 | $0 | $276,880 | $37,706 |
| Investing Cash Flow | -$96,411 | -$155,242 | $256,455 | $132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $1,000 |
| Stock Issued | $397,304 | $463,281 | $189,502 | $203,156 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$6,640 | -$322 | $648 | $35,112 |
| Financing Cash Flow | $390,664 | $462,959 | $190,150 | $239,268 |
| Forex Effect | -$541 | -$2,740 | $0 | $0 |
| Net Chg. in Cash | -$59,265 | -$56,843 | $153,848 | $11,459 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $181,318 | $238,161 | $84,313 | $72,854 |
| End Cash | $122,053 | $181,318 | $238,161 | $84,313 |
| Free Cash Flow | -$364,046 | -$384,110 | -$313,182 | -$265,515 |